Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR)

February 19, 2024 updated by: Phillip Vlisides, University of Michigan

Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR): a Pilot Randomized Controlled Trial

This is a pilot randomized controlled trial that will test whether a multicomponent decision support system will improve the postoperative environment for neurocognitive and clinical recovery in older, high-risk surgical patients. Decision support systems will be tested that provide targeted alerts and recommendations to the Hospital Elder Life Program and family members for delirium prevention.

Study Overview

Status

Completed

Conditions

Detailed Description

Delirium is a distressing and common surgical complication, affecting approximately 20-50% of older surgical patients. Postoperative delirium is associated with increased mortality, cognitive and functional decline, and healthcare resource utilization. Prevention programs have been tested with variable success, but the Hospital Elder Life Program (HELP) has consistently been demonstrated to reduce the incidence and impact of delirium. However, substantial resources are needed for program operations, and complementary support systems may help with patient triage and assessment. Family members and caretakers may be able to provide supplementary support with delirium screening and prevention via targeted, therapeutic activities. Thus, an automated postoperative paging system, which elicits additional, focused support from HELP and family members, may augment delirium prevention activities and reduce associated risk.

The primary objectives of this study are to determine whether pager-based clinical decision support systems bolster HELP- and family-based therapeutic activities. A secondary objective will be to identify facilitators and barriers to delivering therapeutic interventions for both HELP and family members. Overall, this pilot trial will test the hypothesis that a multicomponent decision support system will improve the postoperative environment for neurocognitive and clinical recovery in older, high-risk surgical patients. Patients (n=60) will be randomized to one of four groups in a factorial design: usual care (n=15), HELP-based paging system (n=15), family-based paging system (n=15), or both HELP- and family-based paging system (n=15). The support systems will consist of automated pager alerts to the HELP program and/or family members and caretakers, depending on group allocation, for providing additional delirium evaluation and therapeutic prevention activities. Outcomes will include various clinical, neurocognitive, and functional measures, and performance metrics will be collected regarding HELP- and family-based interventions.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥ 70 years of age
  • Major non-cardiac, non-intracranial neurologic, and non-major vascular surgery
  • Anticipated length of stay at least 72 hours
  • At least one family member, or caretaker, available on each of the first three postoperative days for trial operations

Exclusion Criteria:

  • Emergency surgery
  • Severe cognitive impairment (precluding ability to perform delirium assessments)
  • Planned postoperative ICU admission
  • Non-English speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care Group
Usual care per surgical ward standards
Experimental: HELP Support System
This arm will receive the HELP Support System intervention only
A postoperative page will be sent, on behalf of participants, to the on-call HELP staff. The page will request early evaluation and enhanced therapeutic protocols for delirium prevention.
Experimental: Family Support System
This arm will receive the Family Support system intervention only
Family members and/or caregivers of patients will receive pagers, and alerts will provide recommendations for daily delirium screening and therapeutic activities. Protocols with associated activities will be provided to family members.
Experimental: Combined Support Systems
Participants randomized to this arm will receive both HELP- and family-based support system interventions
A postoperative page will be sent, on behalf of participants, to the on-call HELP staff. The page will request early evaluation and enhanced therapeutic protocols for delirium prevention.
Family members and/or caregivers of patients will receive pagers, and alerts will provide recommendations for daily delirium screening and therapeutic activities. Protocols with associated activities will be provided to family members.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delirium
Time Frame: morning postoperative day one through afternoon of postoperative day three
Any positive delirium screen (yes/no) as determined by the long-form Confusion Assessment Method (n, 0-19)
morning postoperative day one through afternoon of postoperative day three

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Falls
Time Frame: morning postoperative day one through afternoon of postoperative day three
Proportion of patients in each group (%) experiencing at least one fall
morning postoperative day one through afternoon of postoperative day three
Length of Hospital Stay
Time Frame: morning of surgery until day of hospital discharge, up to 30 days
Total number of days (n) spent in the hospital, up to 30 days
morning of surgery until day of hospital discharge, up to 30 days
Discharge Disposition
Time Frame: day of hospital discharge, up to 30 days
Proportion of patients in each group (%) discharged somewhere other than home (e.g., Long-Term Care Facility), up to 30 days
day of hospital discharge, up to 30 days
Delayed Discharge - Cognitive Impairment
Time Frame: day of hospital discharge, up to 30 days
Proportion of patients in each group (%) experiencing delayed discharge, with the documented reason as cognitive impairment
day of hospital discharge, up to 30 days
Mortality
Time Frame: within 30 days after surgery
Incidence (%)
within 30 days after surgery
Delirium Severity
Time Frame: morning postoperative day one through afternoon of postoperative day three
For any patient with a completed delirium assessment, the associated severity score will be recorded using the Confusion Assessment Method Long Form Severity Score (n, 0-19, with higher number indicating more severe delirium)
morning postoperative day one through afternoon of postoperative day three
Depressive Symptoms as Assessed by Hospitalized Anxiety and Depression Scale (HADS-D)
Time Frame: baseline through postoperative day 2
Incidence (%) of positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-D) (n, 0-21, 0 = normal, 21 = presence of severe depression symptoms)
baseline through postoperative day 2
Anxiety Symptoms as Assessed by Hospitalized Anxiety and Depression Scale (HADS-A)
Time Frame: baseline through postoperative day 3
Incidence (%) of positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-A) (n, 0-21, 0 = normal, 21 = presence of severe anxiety symptoms)
baseline through postoperative day 3
New Non-surgical Site Infection
Time Frame: morning of surgery until day of hospital discharge, up to 30 days
Incidence (%) of any new non-surgical site infection while hospitalized
morning of surgery until day of hospital discharge, up to 30 days
Multidrug Resistant Organism Colonization
Time Frame: morning postoperative day one through 30 days after surgery
Incidence (%) of any new multidrug resistant organism colonization
morning postoperative day one through 30 days after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-Day FAM-CAM Assessments
Time Frame: day after discharge through 30 days postoperatively
Incidence (%) of positive FAM-CAM assessments post-discharge
day after discharge through 30 days postoperatively
36-Item Short Form Survey
Time Frame: 30 days after hospital discharge
Comprehensive survey that reports on overall health, functional status, physical/mental well-being, and pains (score range, for both overall scale and domain subscales: n, 0-100, 0 = worst score and 100 = best score in relation to the general state of health and quality of life)
30 days after hospital discharge
PROMIS Cognitive Abilities (Short Form 4a)
Time Frame: 30 days postoperatively
Subjective reporting of cognitive function
30 days postoperatively
Hospital Readmission
Time Frame: within 30 days after discharge
Incidence (%) of hospital readmission
within 30 days after discharge
HELP - Duration of Time
Time Frame: postoperative day one through postoperative day three
Cumulative length of time spent with HELP team members
postoperative day one through postoperative day three
HELP - Visitation
Time Frame: postoperative day one through postoperative day three
Proportion of patients successfully visited by the program
postoperative day one through postoperative day three
HELP - Time to Evaluation
Time Frame: postoperative day one through postoperative day three
Time until initial HELP evaluation
postoperative day one through postoperative day three
Family Intervention - Duration of Time
Time Frame: postoperative day one through postoperative day three
Cumulative duration of time spent with family members/caretakers at the bedside
postoperative day one through postoperative day three
Family Intervention - Proportion of Daily Tasks Completed
Time Frame: postoperative day one through postoperative day three
The proportion of family-based daily tasks successfully completed will be reported
postoperative day one through postoperative day three
Family Intervention - Length of Time, Stimulating Activity
Time Frame: postoperative day one through postoperative day three
Cumulative length of time spent on prescribed stimulating activities
postoperative day one through postoperative day three
Agreement - FAM-CAM and Research-based CAM Assessments
Time Frame: postoperative day one through postoperative day three
Agreement will be assessed, via Cohen's kappa, between FAM-CAM and research-based CAM assessments.
postoperative day one through postoperative day three

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Phillip E Vlisides, MD, University of Michigan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 21, 2019

Primary Completion (Actual)

July 27, 2022

Study Completion (Actual)

July 27, 2022

Study Registration Dates

First Submitted

June 27, 2019

First Submitted That Met QC Criteria

July 2, 2019

First Posted (Actual)

July 5, 2019

Study Record Updates

Last Update Posted (Estimated)

February 21, 2024

Last Update Submitted That Met QC Criteria

February 19, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Clinical Trials on HELP Support System

3
Subscribe